CAR macrophage-neutrophil hybrids show anti-tumor activity in solid tumors
Engineered CAR macrophage-neutrophil hybrids delivered anti-tumor effects in solid tumors, extending cell therapy beyond conventional T-cell approaches.
This section contains the website’s posts.